The purpose of this research protocol is to determine if the same effects are observed in
vivo in humans through a randomized controlled study. Data regarding a novel mechanism of the
widely used statin class of medications on the mineralocorticoid pathway would likely have
significant clinical implications on the future management of hypertension and other
cardiovascular disease given the known pleiotropy of aldosterone action.